Streptococcus pneumoniae keratitis: epidemiology and outcomes over 6 years in a French eye care center
摘要
We evaluated the epidemiology, clinical features, microbiology, management and visual outcome of Streptococcus pneumoniae keratitis.
MethodsWe retrospectively reviewed the medical charts of patients diagnosed with culture-proven Streptococcus pneumoniae keratitis in a French tertiary center between January 2015 and December 2020.
ResultsWe analyzed data from 51 eyes of 51 patients with Streptococcus pneumoniae keratitis followed for 64 (19–105) days, out of a total of 1222 eyes with documented bacterial keratitis (4.17%). Most cases (55%) occurred in winter or spring (p = 0.037). A local or systemic risk factor was identified in 39 (76%) and 32 (63%) eyes respectively: previous ocular surgery (55%) followed by glaucoma (24%), and diabetes (18%). Forty-one patients (80%) with severe keratitis remained in hospital for 7 (1–60) days. Polymicrobial infection was detected in 6 eyes (12%) and multidrug resistant strain in 9 eyes (18%). Medical treatment lasted 36 (21–60) days. Adjuvant surgery was required in 13 eyes (25%) mainly for delayed ulcer healing (n = 10), with amniotic membrane transplantation (n = 12) or tectonic keratoplasty (n = 1). In multivariate analysis, endothelial plaque (OR 65.87, p = 0.028), hypopyon (OR 17.8, p = 0.040), and infiltrate > 5mm2 (OR 2.49, p = 0.012) were significantly associated with the need for adjuvant surgery. Baseline visual acuity (VA) 2.00(1.33-2.00) logMAR did not improve significantly at final visit (p = 0.121). Eyes requiring adjuvant surgery had worse final VA (p = 0.009).
ConclusionStreptococcus pneumoniae keratitis are rare in France but may be sight-threatening. Overall VA is poor, most of patients require hospitalization, and some local factors at presentation predict the need for adjuvant surgery.